IPSC - Century Therapeutics, Inc.
IEX Last Trade
1.065
-0.015 -1.408%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:29:38 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$1.08
-0.02
-1.39%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-16 | 2023-05-11 | 2023-08-09 | 2023-11-09 | 2024-03-14 | 2024-05-09 | |
| Total revenue | 1.396 M | 2.224 M | 521.000 K | 1.720 M | 99.000 K | 148.000 K | 268.000 K | 855.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.396 M | 2.224 M | 521.000 K | 1.720 M | 99.000 K | 148.000 K | 268.000 K | 855.000 K | |
| 59.31% | -76.57% | 230.13% | -94.24% | 49.49% | 81.08% | 219.03% | |||
| Operating expenses | 32.747 M | 33.962 M | 33.827 M | 33.801 M | 30.956 M | 31.774 M | 30.885 M | 32.164 M | |
| Selling general and admin | 8.253 M | 8.064 M | 8.242 M | 8.902 M | 8.229 M | 8.986 M | 8.589 M | 8.743 M | |
| Research and development | 24.494 M | 25.898 M | 25.585 M | 24.899 M | 22.727 M | 22.788 M | 22.296 M | 23.421 M | |
| Total expenses | 32.747 M | 33.962 M | 33.827 M | 33.801 M | 30.956 M | 31.774 M | 30.885 M | 32.164 M | |
| 3.71% | -0.40% | -0.08% | -8.42% | 2.64% | -2.80% | 4.14% | |||
| Operating income | -31.351 M | -31.738 M | -33.306 M | -32.081 M | -30.857 M | -31.626 M | -30.617 M | -31.309 M | |
| Ebit | -31.351 M | -31.738 M | -33.306 M | -32.081 M | -30.857 M | -31.626 M | -30.617 M | -31.309 M | |
| Pretax income | -30.970 M | -30.724 M | -31.650 M | -30.056 M | -32.341 M | -32.128 M | -40.267 M | -28.061 M | |
| -0.79% | 3.01% | -5.04% | 7.60% | -0.66% | 25.33% | -30.31% | |||
| Income tax | 18.000 K | 25.000 K | 32.000 K | 1.208 M | 950.000 K | 592.000 K | -869.000 K | 1.000 K | |
| Net income basic | -30.988 M | -30.749 M | -31.682 M | -31.264 M | -33.291 M | -32.720 M | -39.398 M | -28.062 M | |
| 0.77% | -3.03% | 1.32% | -6.48% | 1.72% | -20.41% | 28.77% | |||
| Net income | -30.988 M | -30.749 M | -31.682 M | -31.264 M | -33.291 M | -32.720 M | -39.398 M | -28.062 M | |
| 0.77% | -3.03% | 1.32% | -6.48% | 1.72% | -20.41% | 28.77% |